Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Immunology
  •  General Oncology
  •  Melanoma/Skin Cancer
  •  Chemotherapy and Radiotherapy
  •  Breast Cancer
  •  Neoadjuvant Therapy
  •  Radiation Therapy
  •  Blood Cancer

Abstract

Citation: Clin Oncol. 2022;7(1):1934.DOI: 10.25107/2474-1663.1934

Influence of Hypertension and Diabetes on Postoperative Outcomes in Cancer Patients Undergoing Moderate/High Risk Surgical Procedures

Lafayete William Ferreira Ramos, Beatriz Nery Nascimento, Gabriel Rossi Silva, Marcos Vinícius Ferreira Ramos, Barbara Cristina Ferreira Ramos, Cristiano Freitas de Souza and Pedro Amoedo Fernandes

São Camilo Oncologia, São Paulo, Brazil
Centro Universitário São Camilo, São Paulo, Brazil
Faculty of Medicine of Marilia, Marília, Brazil

*Correspondance to: Lafayete William Ferreira Ramos 

 PDF  Full Text Research Article | Open Access

Abstract:

Background: Systemic Hypertension (HTN) and Diabetes Mellitus (DM) are believed to be risk factors for adverse postoperative outcomes in patients undergoing surgical interventions, but evidence is lacking. This retrospective study evaluated the effects of HTN and DM, alone or in combination, on postoperative outcomes of elective non-cardiac surgery in cancer patients.
Materials and Methods: Patients (n=844) with malignancies, who underwent elective surgery at a tertiary hospital, were categorized into healthy (group A, n=339), hypertensive (group B, n=357), diabetic (group C, n=21), and hypertensive and diabetic (group D, n=127) groups. Preoperatively, all patients had systolic blood pressure ≤ 160 mmHg and plasma glucose level ≤ 140 mg/dl. Postoperative in-hospital morbidity and mortality were compared among groups.
Results: Postoperative complications occurred in 22 (6.5%), 21 (5.9%), 2 (9.5%), and 11 (8.7%) patients in groups A, B, C, and D, respectively (p=0.712). HTN (p=0.538), DM (p=0.990), and HTN+DM (p=0.135) did not impact the occurrence of adverse events. Patients with higher surgical risk (ASA III or IV) and those with longer surgical time had higher morbidity and mortality
(p=0.001, p<0.001, respectively). In multiple logistic regression analysis, ASA status and surgical time were independent risk factors for postoperative complications (both p<0.001).
Conclusion: Cancer patients with preoperative comorbidities, such as HTN and DM, alone or in combination, regardless of other characteristics, do not have an increased risk of adverse postoperative outcomes.

Keywords:

Diabetes mellitus; Hypertension; Oncologic surgery; Postoperative outcomes

Cite the Article:

Ramos LWF, Nascimento BN, Silva GR, Ramos MVF, Ramos BCF, de Souza CF, et al. Influence of Hypertension and Diabetes on Postoperative Outcomes in Cancer Patients Undergoing Moderate/High Risk Surgical Procedures. Clin Oncol. 2022;7:1934..

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Thromboxane-Prostanoid Receptor Signaling as Potential Therapy for Pulmonary Fibrosis
 PDF  Full Text
Expression of the Oncoprotein E5 from Human papillomavirus and miR-203 in Pre-Cancer Lesions and Cervical Cancer
 Abstract  PDF  Full Text
View More...